XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
  Anti-Inflammatory
  Antivirals
  Antihypertensives
  Anticholesterol
  Anti-Clotting Drugs
  Anti Cancer Drugs
  Hypnotics
  PPI
  Antibiotics
  Analgesics
  Surfactants
  Fatty Acids
   Omega 3 Fatty Acids
  Adrenergics
  Metals
  Varenicline
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Omega 3 Fatty Acids Channel
subscribe to Omega 3 Fatty Acids newsletter

Latest Research : Pharmacology : Fatty Acids : Omega 3 Fatty Acids

   DISCUSS   |   EMAIL   |   PRINT
Omega-3 and Propofol Combination offers hope for new anti-breast cancer drugs
Jun 8, 2005, 19:43, Reviewed by: Dr. Priya Saxena

"These results suggest that the novel propofol-DHA and propofol-EPA conjugates reported here may be useful for the treatment of breast cancer"

 
Omega-3, the fatty acid found in oily fish, could be combined with a commonly used anesthetic to develop drugs to treat breast cancer, according to research published today in the journal Breast Cancer Research.

Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibiting cancer cell migration by 50% and significantly reducing their metastatic activity. These new compounds could be developed into a new family of anti-cancer drugs.
Dr Rafat Siddiqui, from the Methodist Research Institute and Indiana University in Indianapolis, and his colleagues studied the effect of two Omega-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), combined with propofol on a breast cancer cell line in vitro. Omega-3 fatty acids such as DHA and EPA have a minimal effect on cancer cells when applied alone. Propofol is a potent anti-oxidant known to inhibit cancer cell migration by only 5-10%.

The results of the study show that propofol and DHA or EPA have a much more significant effect on cancer cells when used in combination, as conjugates, than when used alone. The conjugates inhibit cancer cell adhesion by 15% and 30% respectively, reduce cell migration by 50% and increase apoptosis by 40%.

"These results suggest that the novel propofol-DHA and propofol-EPA conjugates reported here may be useful for the treatment of breast cancer" conclude Siddiqui and colleagues.

Malignant cancer cells are highly invasive cells that have lost the ability to sense cues from their environment. As a result, they start dividing abnormally, migrate and accumulate into malignant tumours, in a process called metastasis, which is potentially life-threatening. The aim of anti-cancer drugs is therefore to prevent the cells from dividing abnormally and from spreading, to kill the cells, or to cause the cells to kill themselves.

Fatty acids are often attached to drugs, because they facilitate the absorption of the drugs by the cells. Siddiqui and colleagues explain that DHA and EPA might have had this effect on propofol. They add "It is possible that these conjugates provide a mechanism whereby propofol can be retained in cell membranes for a longer duration and therefore enhance its anticancer effects".

Omega-3 fatty acids, like those found in oily fish such as tuna, salmon, herring, sardines and mackerel, are already known to have many positive health benefits. They are commonly recommended for maintaining a healthy heart, as they are known to reduce cholesterol levels and thought to help prevent cardiovascular disease. Research suggests that Omega-3 may also protect against arthritis, lupus, and asthma and help people with biopolar disorder.
 

- Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells Rafat A Siddiqui1, Mustapha Zerouga, Min Wu, Alicia Castillo, Kevin Harvey, Gary P Zaloga and William Stillwell Breast Cancer Research 2005, 7:R645-R654 (7 June 2005)
 

This article is available free of charge, according to Breast Cancer Research 's Open Access policy at http://breast-cancer-research.com/content/pdf/bcr1036.pdf

 
Subscribe to Omega 3 Fatty Acids Newsletter
E-mail Address:

 

Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells
Rafat A Siddiqui1, Mustapha Zerouga, Min Wu, Alicia Castillo, Kevin Harvey, Gary P Zaloga and William Stillwell
Breast Cancer Research 2005, 7:R645-R654 (7 June 2005)


Related Omega 3 Fatty Acids News

Omega-3 fatty acids inhibit growth of liver cancer cells
Researchers create pigs that produce heart-healthy omega-3 fatty acids
Evidence for omega 3 fats less conclusive: Systematic Review
Omega-3 Fatty Acids in Oily Fish like Salmon could block Prostate Cancer
Omega 3 fatty acids influence mood, impulsivity and personality
Omega-3 and Propofol Combination offers hope for new anti-breast cancer drugs


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us